Skeletal Effects of Estrogen Are Mediated by Opposing Actions of Classical and Nonclassical Estrogen Receptor Pathways
Open Access
- 1 November 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 20 (11) , 1992-2001
- https://doi.org/10.1359/jbmr.050713
Abstract
ERα acts either through classical (ERE‐mediated) or nonclassical (non‐ERE) pathways. The generation of mice carrying a mutation that eliminates classical ERα signaling presents a unique opportunity to study the relative roles of these pathways in bone. This study defines the skeletal phenotype and responses to ovariectomy and estrogen replacement in these mice. Introduction: Estrogen receptor α (ERα) can act either through classical estrogen response elements (EREs) or through non‐ERE (nonclassical) pathways. To unravel these in bone, we crossed mice heterozygous for a knock‐in mutation abolishing ERE binding (nonclassical ERα knock‐in [NERKI]) with heterozygote ERα knockout mice and studied the resulting female ERα+/+, ERα+/NERKI, and ERα−/NERKI mice. The only ERα present in ERα−/NERKI mice is incapable of activating EREs but can signal through nonclassical pathways, whereas ERα+/NERKI mice may have a less drastic alteration in the balance between classical and nonclassical estrogen signaling pathways. Materials and Methods: BMD was measured using DXA and pQCT at 3 months of age (n = 46–48/genotype). The mice were randomly assigned to sham surgery, ovariectomy, ovariectomy + estradiol (0.25 μg/day), or ovariectomy + estradiol (1.0 μg/day; n = 10–12/group) and restudied 60 days later. Results and Conclusions: At 3 months of age, both the ERα+/NERKI and ERα−/NERKI mice had deficits in cortical, but not in trabecular, bone. Remarkably, changes in cortical bone after ovariectomy and estrogen replacement in ERα−/NERKI mice were the opposite of those in ERα+/+ mice. Relative to sham mice, ovariectomized ERα−/NERKI mice gained more bone (not less, as in ERα+/+ mice), and estrogen suppressed this increase (whereas augmenting it in ERα+/+ mice). Estrogen also had opposite effects on bone formation and resorption parameters on endocortical surfaces in ERα−/NERKI versus ERα+/+ mice. Collectively, these data show that alteration of the balance between classical and nonclassical ERα signaling pathways leads to deficits in cortical bone and also represent the first demonstration, in any tissue, that complete loss of classical ERE signaling can lead to paradoxical responses to estrogen. Our findings strongly support the hypothesis that there exists a balance between classical and nonclassical ERα signaling pathways, which, when altered, can result in a markedly aberrant response to estrogen.Keywords
This publication has 39 references indexed in Scilit:
- Altered pharmacology and distinct coactivator usage for estrogen receptor-dependent transcription through activating protein-1Proceedings of the National Academy of Sciences, 2005
- Insulin-like growth factor-binding protein-2 (IGFBP-2) overexpression negatively regulates bone size and mass, but not density, in the absence and presence of growth hormone/IGF-I excess in transgenic miceBrain Structure and Function, 2002
- Effects of Liver-Derived Insulin-Like Growth Factor I on Bone Metabolism in MiceJournal of Bone and Mineral Research, 2002
- An Estrogen Receptor (ER)α Deoxyribonucleic Acid-Binding Domain Knock-In Mutation Provides Evidence for Nonclassical ER Pathway Signaling in VivoMolecular Endocrinology, 2002
- Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-β in bone remodeling in females but not in malesBone, 2002
- ER Gene Expression in Human Primary Osteoblasts: Evidence for the Expression of Two Receptor ProteinsMolecular Endocrinology, 2001
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- Steroid hormone receptors: Many Actors in search of a plotCell, 1995
- Identification of an estrogen response element upstream of the human c-fosgene that binds the estrogen receptor and the AP-1 transcription factorNucleic Acids Research, 1990